CellaVision Reports Q3 2026 Financial Results

CellaVision reported Q3 2026 net sales of SEK 200 million, up 13.6% year over year, with organic sales growth of 13.4%. The EBITDA margin increased to 32% from 28%, profit before tax reached SEK 51 million, and earnings per share rose to SEK 1.68. Sales were strong in the Americas and APAC, while EMEA declined against a strong prior-year comparison. An employee option program for the CEO was adopted following an Extraordinary General Meeting resolution on September 2, 2026.